SourceBio International PLC Director/PDMR Shareholding (3970D)
02 March 2022 - 11:28PM
UK Regulatory
TIDMSBI
RNS Number : 3970D
SourceBio International PLC
02 March 2022
2 March 2022
SourceBio International plc
(" SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc ("the Company") has been notified
that on 2 March 2022, Harwood Capital LLP transferred 9,474
ordinary shares of 0.15 pence each in the Company ("Ordinary
Shares") to Limited Partners of Harwood Private Equity IV L.P.
("HPE4") in order to satisfy distributions, in the normal course of
business.
Christopher Mills, Non-Executive Director of the Company is
Chief Executive of Harwood Capital LLP.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP as investment
manager
---------------------------------- -----------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Christopher Mills is a non-executive
director of the issuer and Chief
Executive of the investment manager
---------------------------------- -----------------------------------------
b) Initial notification Initial Notification
/Amendment
---------------------------------- -----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------
a) Name SourceBio International Plc
---------------------------------- -----------------------------------------
b) LEI 213800KY4C9WU7WBW518
---------------------------------- -----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0015 each
financial instrument,
type of instrument
Identification code GB00BKSB1674
b) Nature of the transaction Transfer of shares
---------------------------------- -----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 9,474
----------
-------------------------------------
d) Aggregated information
N/A - single transaction
Volume
Price
e) Date of the transaction 2 March 2022
f) Place of the transaction Off market
---------------------------------- -----------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFFFVRIFIIF
(END) Dow Jones Newswires
March 02, 2022 07:28 ET (12:28 GMT)
Sourcebio (LSE:SBI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Sourcebio (LSE:SBI)
Historical Stock Chart
From Dec 2023 to Dec 2024
